The company has fixed a price band of Rs 371-390 per share for the IPO, which means that the investors are willing to pay about Rs 410 for one share of the company.
Gland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to ‘Reduce’ with a
Sagility India raised Rs 945 crore from anchor investors, including prominent mutual funds and institutions, at Rs 30 per share. The company’s IPO, entirely an
Advertiser Disclosure
Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.
Disclaimer
It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information
Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003